| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/12/2005 | WO2004072233A3 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 05/12/2005 | WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/12/2005 | WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 05/12/2005 | WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/12/2005 | WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/12/2005 | US20050102717 Crop plant cystatin proteinase inhibitors and methods of use |
| 05/12/2005 | US20050102713 Expression vector comprising regulatory sequences associated with expression of antifungal protein for use as tool in generating transgenic plants with enhanced exogeneous gene transcription and insect and herbicide resistance |
| 05/12/2005 | US20050101765 Photocleavable protecting groups |
| 05/12/2005 | US20050101557 Immunostimulatory nucleic acid molecules |
| 05/12/2005 | US20050101554 Methods for treating and preventing infectious disease |
| 05/12/2005 | US20050101013 Antisense nucleotide sequences for modulating the expression of signal transducer and activator of transcription (STAT) proteins; cancer and tumor treatment; gene expression inhibition |
| 05/12/2005 | US20050100995 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity |
| 05/12/2005 | US20050100989 FSH glycosylation mutant |
| 05/12/2005 | US20050100986 Compositions and methods for targeting a polypeptide to the central nervous system |
| 05/12/2005 | US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy |
| 05/12/2005 | US20050100948 Dye-labeled ribonucleotide triphosphates |
| 05/12/2005 | US20050100942 Nucleotide sequences coding RNA for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/12/2005 | US20050100932 Sequencing a polynucleotide; stopping an extension cycle in a sequence by synthesis reaction before the reaction has run to near or full completion |
| 05/12/2005 | US20050100920 Nucleic acid encoding Bacillus stearothermophilus polc polymerase subunit |
| 05/12/2005 | US20050100906 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1. |
| 05/12/2005 | US20050100896 Amino acid sequences comprising dombrook antigens for use as diagnostic tool in transfusion medicine; blood typing |
| 05/12/2005 | US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery |
| 05/12/2005 | US20050100885 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/12/2005 | US20050100554 Chimeric polypeptides, vectors and cells; test for precancerous cells; human papilloma virus |
| 05/12/2005 | US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | CA2551074A1 Hcv ns3-ns4a protease resistance mutants |
| 05/12/2005 | CA2544708A1 Liver cancer biomarkers |
| 05/12/2005 | CA2544365A1 Modified anti-cd52 antibody |
| 05/12/2005 | CA2543954A1 Method of designing sirnas for gene silencing |
| 05/12/2005 | CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 05/12/2005 | CA2542904A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof |
| 05/12/2005 | CA2542768A1 Fluorescent probes for dna detection by hybridization with improved sensitivity and low background |
| 05/12/2005 | CA2542542A1 Method of detecting a quantity of methylation at a locus |
| 05/12/2005 | CA2541856A1 Modified polypeptides with therapeutic activity and methods of use |
| 05/12/2005 | CA2541852A1 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 05/12/2005 | CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | CA2536238A1 Humanization of antibodies |
| 05/11/2005 | EP1529845A2 Fusion glycoprotein from HCMV and HSV |
| 05/11/2005 | EP1529844A2 Complex formation for the stabilisation and purification of proteins of interest |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/11/2005 | EP1218548B1 Typing of human enteroviruses |
| 05/11/2005 | EP0670373B1 Probe for diagnosing candida-infections |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1613865A Trans-oligonucleotide, medicinal composition containing it and use thereof |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/10/2005 | US6892141 Primer design system |
| 05/10/2005 | US6891089 Grass cultivar named ‘Benest 1’ and ‘Dongrae Koryogi’-specific STS marker |
| 05/10/2005 | US6891026 Detecting and classification of viral nucleotide sequences; obtain sample, incubate with sequence preferential probe, detect signal from bound probes |
| 05/10/2005 | US6890908 Modified ribozymes |
| 05/10/2005 | US6890750 For measurement of activation/inhibition of pathways converging at transcriptional activators in cells |
| 05/10/2005 | US6890741 Detecting preferential particles in sample; obtain sample, incubate with primers, amplify, detect amplicons, presence of amplicons indicates the presence of target particle |
| 05/10/2005 | US6890718 Kit for the amplification and propagation of preferential nucleotide sequences |
| 05/10/2005 | US6890712 Cycling DNA/RNA amplification electrochemiluminescent probe assay |
| 05/10/2005 | US6890554 Genetic immunization with cationic lipids |
| 05/10/2005 | US6890483 Non-luminescent substrate |
| 05/10/2005 | CA2118518C Over expression of single-stranded molecules |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040428A2 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/06/2005 | WO2005040399A2 Methods for quantitative determination of methylation density in a dna locus |
| 05/06/2005 | WO2005040386A2 A vector modification for versatile use of expressed products |
| 05/06/2005 | WO2005040367A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 05/06/2005 | WO2005040341A2 Human prostaglandin ep4 receptor variants and methods of using same |
| 05/06/2005 | WO2005040229A2 Ldl receptor class a and egf domain monomers and multimers |
| 05/06/2005 | WO2005040188A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | WO2005040187A2 The use of sirna silencing in the prevention of metastasis |
| 05/06/2005 | WO2005040186A2 Method for preparing a modified host cell |
| 05/06/2005 | WO2005040180A2 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression |
| 05/06/2005 | WO2005040074A2 Crick-watson base paired dendrimer structures |
| 05/06/2005 | WO2005039282A1 Drosophila transgenic animal models for the treatment of human genetic diseases caused by expansions of microsatellites which contain the trinucleotide ctg |
| 05/06/2005 | WO2005017186A3 Method for rapid identification of alternative splicing |
| 05/06/2005 | WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/06/2005 | WO2005014848A3 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2004110345A8 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 05/06/2005 | WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 05/06/2005 | WO2004098377A3 Methods and compositions for diagnosis and therapy of parkin-associated disorders |
| 05/06/2005 | WO2004093785A3 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 05/06/2005 | WO2004090154A3 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 05/06/2005 | WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 05/06/2005 | WO2004078949A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 05/06/2005 | WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids |
| 05/06/2005 | WO2004041889A3 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/06/2005 | WO2004037979A3 Improved sso7-polymerase conjugate proteins |
| 05/06/2005 | WO2003102146A3 Aptamer constructs |
| 05/06/2005 | CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/06/2005 | CA2543786A1 Methods and systems for inferring traits to manage non-beef livestock |
| 05/06/2005 | CA2543360A1 Ldl receptor class a and egf domain monomers and multimers |
| 05/06/2005 | CA2542526A1 Methods for quantitative determination of methylation density in a dna locus |
| 05/06/2005 | CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 05/06/2005 | CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | CA2534996A1 The use of sirna silencing in the prevention of metastasis |
| 05/06/2005 | CA2530738A1 Prediction of likelihood of cancer recurrence |
| 05/05/2005 | US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants |
| 05/05/2005 | US20050097638 Transcriptional regulation of plant biomass and abiotic stress tolerance |
| 05/05/2005 | US20050096289 Methods and compositions for modulating tissue factor |
| 05/05/2005 | US20050096287 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin a solution in water |
| 05/05/2005 | US20050096273 Regulation of matrix metalloproteinases by PSP94 family members |